Showing results (161-170 of 193) with videos related to
Sort By:
Pageof 20
Journal of Clinical Medicine|June 13, 2025
Contrast-Induced Nephropathy (CIN) After Invasive Treatment of Acute Coronary Syndromes-Predictors, Short and Long-Term OutcomeJanusz Sielski, Karol Kaziród-Wolski, Aleksandra M Piotrowska, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 24, 2016
Assessment of quality of life in patients after surgical and transcatheter aortic valve replacementTomasz Tokarek, Zbigniew Siudak, Artur Dziewierz, et al.Journal of Clinical Medicine|November 11, 2022
Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)Artur Dziewierz, Barbara Zdzierak, Krzysztof P Malinowski, et al.Journal of Clinical Medicine|July 29, 2023
Single versus Dual-Operator Approaches for Percutaneous Coronary Interventions within Chronic Total Occlusion-An Analysis of 27,788 PatientsRafał Januszek, Giuseppe De Luca, Wojciech Siłka, et al.Diabetes Research and Clinical Practice|March 9, 2025
Association of quality of care and long-term mortality risk for individuals presenting with ST-segment myocardial infarction (STEMI) by diabetes mellitus status: A nationwide cohort studyAndrew Cole, Nicholas Weight, Harindra C Wijeysundera, et al.Kardiologia Polska|October 22, 2013
Long-term follow-up of mesh-covered stent implantation in patients with ST-segment elevation myocardial infarctionDariusz Dudek, Artur Dziewierz, Paweł Kleczyński, et al.Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|May 6, 2026
The relationship between the Fibrosis-4 (FIB-4) index, occurrence of contrast-induced nephropathy, and prognosis after percutaneous coronary intervention in acute coronary syndromesJanusz Sielski, Karol Kaziród-Wolski, Aleksandra M Piotrowska, et al.American Heart Journal|September 29, 2009
Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registryTomasz Rakowski, Zbigniew Siudak, Artur Dziewierz, et al.Kidney Medicine|February 23, 2023
CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020Ofer Kobo, Dmitry Abramov, Simon Davies, et al.Journal of Cardiovascular Development and Disease|September 27, 2023
The Effect of Daylight-Saving Time on Percutaneous Coronary Intervention Outcomes in Acute Coronary Syndrome Patients-Data from the Polish National Registry of Percutaneous Coronary Interventions (ORPKI) in the Years 2014-2022Karol Kaziród-Wolski, Aleksandra Piotrowska, Janusz Sielski, et al.Pageof 20